UNION therapeutics A/S: Financial statements 2021
CVR: 33963750
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
UNION therapeutics A/S (CVR 33963750) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 118,912,000 and a net result of DKK -56,026,000 compared with DKK -80,896,000 the year before. The profit margin was -47.1%. Equity in the 2021 report amounted to DKK 49,380,000. The solvency ratio was 17.3%. The company had 26 employees in the financial year.
- Revenue
- DKK 118,912,000
- Profit/Loss
- DKK -56,026,000
- Equity
- DKK 49,380,000
- Total Assets
- DKK 284,925,000
- Employees
- 26
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 118.9M | - | -56M | 49.4M | 26 |
| 2020 | 0 | - | -80.9M | -58.4M | - |
| 2019 | 11.6M | - | -12.9M | -38.3B | - |
| 2018 | 0 USD | - | -7.8M USD | -5.3M USD | - |
| 2017 | 315K USD | - | -5.4M USD | 1.9M USD | - |
Official annual report
Find more companies like UNION therapeutics A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of August 31, 2021, Morten Otto Alexander Sommer is registered as director of UNION therapeutics A/S.
As of July 12, 2021, Gitte Pugholm Aabo has joined the board of directors of UNION therapeutics A/S.
As of July 12, 2021, Arthur Joseph Higgins has joined the board of directors of UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -80,896,000.
As of January 1, 2021, Kim Domela Kjøller is registered as adm. dir. of UNION therapeutics A/S.
As of January 1, 2021, Morten Otto Alexander Sommer has stepped down as director of UNION therapeutics A/S.
About UNION therapeutics A/S
UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.
